Haloperidol 0.416-mg/mL, Hyoscine 4.9-mg/mL, and Tramadol 16.67-mg/mL in 0.9% Sodium Chloride Injection

Author(s): Allen Loyd V Jr

Issue: Sep/Oct 2010 - Supporting Quality Pharmaceutical Compounding World Wide
View All Articles in Issue

Page(s): 427

Haloperidol 0.416-mg/mL, Hyoscine 4.9-mg/mL, and Tramadol 16.67-mg/mL in 0.9% Sodium Chloride Injection Page 1

Download in electronic PDF format for $65

Abstract: A formulation for preparing Haloperidol 0.416-mg/mL, Hyoscine 4.9-mg/mL, and Tramadol 16.67-mg/mL in 0.9% Sodium Chloride Injection. Includes ingredients, method of preparation, discussion, and references for the compounding pharmacist.

Related Keywords: Loyd V. Allen, Jr., PhD, RPh, formulation, haloperidol, hyoscine, tramadol, pain relief, secretions, psychosis, delirium, palliative care, cancer, antipsychotic agent, antimuscarinic, antisecretory agent, analgesic, analgesia

Related Categories: FORMULATIONS, MENTAL HEALTH, PAIN MANAGEMENT, ALLERGY/IMMUNOLOGY/INFLAMMATION, DOSAGE FORMS/DRUG CARRIERS, RESPIRATION/LUNG/BREATHING

Printer-Friendly Version

Title/Author (Click for Abstract / Details / Purchase)	Issue/Page View/Buy
Related Articles from IJPC
Wetting and/or Solubilizing Agents, Featured Excipient: Allen Loyd V Jr	Jul/Aug 2001 Pg. 310-312
Haloperidol 0.416-mg/mL, Hyoscine 4.9-mg/mL, and Tramadol 16.67-mg/mL in 0.9% Sodium Chloride Injection Allen Loyd V Jr	Sep/Oct 2010 Pg. 427
Morphine 6-mg/mL, Haloperidol 0.5-mg/mL, and Hyoscine 6-mg/mL Infusion Allen Loyd V Jr	Nov/Dec 2011 Pg. 504
Rapid-Dissolve Technology: An Interview With Loyd V. Allen, Jr., PhD, RPh Allen Loyd V Jr	Nov/Dec 2003 Pg. 449-450
Compounded Drugs of Value in Outpatient Hospice and Palliative Care Practice McNulty John P, Muller George	May/Jun 2014 Pg. 190-200
Compounding for the Effects of Weapons of Mass Destruction Sammarco Domenic A	Jan/Feb 2003 Pg. 10-15 View Sample
Compounded Analgesic Therapy for Disorders of Movement: Arthritis, Neuropathic Pain, and Postpolio Syndrome Brown Scott, Erickson Brian, Muller George, Bryant-Snure Susan J, Mestayer Richard F III	May/Jun 2010 Pg. 182-192
Haloperidol 0.5-mg/mL in SyrSpend SF pH4 Allen Loyd V Jr	Sep/Oct 2021 Pg. 417
Palliative Care and Compounding for Household Pets Gaskins Jessica L	Nov/Dec 2012 Pg. 452-455
Haloperidol 5-mg/mL Injection Allen Loyd V Jr	Nov/Dec 2017 Pg. 493